Novarex Co., Ltd. (194700) Stock Forecast & Analysis

Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for Novarex Co., Ltd. (194700:KRX), powered by AI.

Current Price
₩14,080
P/E Ratio
7.3
Market Cap
257.0B
Sector
Consumer Defensive
What is the Novarex Co., Ltd. stock price forecast?

Novarex Co., Ltd. is currently trading at ₩14,080. View real-time AI analysis on Alpha Lenz.

What is Novarex Co., Ltd. insider trading activity?

View the latest insider trading data for Novarex Co., Ltd. on Alpha Lenz.

What is Novarex Co., Ltd.'s P/E ratio?

Novarex Co., Ltd.'s P/E ratio is 7.3.

Novarex Co., Ltd.

KRX · 194700
₩14,080+100(+0.72%)Market closedKRX regular session 09:00–15:30 KST
Ask about Novarex Co., Ltd.'s future dividend policy...
Alpha Chat Insight

Novarex Co., Ltd. trades at a P/E of 7.3 (undervalued) with solid ROE of 15.0%. 3Y revenue CAGR of 12.8% highlights clear growth momentum.

Ask for details

Company Overview

Novarex Co., Ltd. is a renowned Korean company primarily engaged in the development and manufacturing of health functional foods and nutraceutical products. As a pivotal player in the nutraceutical industry, its core function is to harness the synergy between biotechnology and nutritional advancements to create innovative health products that cater to a wide array of health conditions and consumer needs. The company offers a diverse portfolio that includes dietary supplements, functional beverages, and vitamins, targeting both domestic and international markets. Novarex Co., Ltd. impacts various sectors including healthcare, wellness, and nutrition by fostering healthier lifestyle choices through scientifically backed solutions. With its production facilities adhering to stringent quality standards, the company positions itself as a leader in the fast-growing wellness industry, driving innovation and setting benchmarks in product efficacy and safety. Through strategic partnerships and a commitment to research and development, Novarex Co., Ltd. plays a significant role in the evolving landscape of functional foods, contributing significantly to the market's expansion and increased consumer interest in preventive health care.

CEO권석형
SectorConsumer Defensive
IndustryPackaged Foods
Employees436

Company Statistics

FY 2025

Profile

₩257,028,259,840Market Cap
₩404,259,788,620Revenue
18.25MShares Out
436Employees

Margins

17.34%Gross
13.48%EBITDA
10.65%Operating
11.05%Pre-Tax
8.90%Net

Valuation

7.26P/E
1.02P/B
0.64EV/Sales
4.49EV/EBITDA
41.61P/FCF

Growth (CAGR)

12.80%Rev 3Yr
12.65%Rev 5Yr
19.57%Op Inc 3Yr
9.79%Op Inc 5Yr
21.72%Net Inc 3Yr
7.54%Net Inc 5Yr

Returns

11.08%ROA
14.99%ROE
14.02%ROIC

Financial Health

₩49,601,942,110Cash & Cash Equivalents
₩55,312,921,050Net Debt
41.20%Debt/Equity
N/AInterest Cov

Frequently Asked Questions

Novarex Co., Ltd. (ticker: 194700) is a company listed on KRX in the Consumer Defensive sector (Packaged Foods). It has approximately 436 employees. Market cap is $257.0B.

The current price is ₩14,080 with a P/E ratio of 7.26x and P/B of 1.02x.

ROE is 14.99% and operating margin is 10.65%. Annual revenue is $404.3B.

Alpha Lenz
Singapore
Treasurer Pte Ltd | License: 202346277E
9 Straits View Marina One West Tower #05-07 Singapore 018937
contact@treasurer.co.kr
©2026 Treasurer Pte Ltd. All rights reserved.
Novarex Co., Ltd. (194700) Stock Forecast 2026 ₩14,080 — Price, Financials & Analyst Targets | Alpha Lenz